Author(s):
Pandurang J. Patole, Jameel Ahmed S. Mulla, Shubham A. Ghare, Rutvik B. Date
Email(s):
jameelahmed5@gmail.com
DOI:
10.52711/2231-5675.2025.00025 
Address:
Pandurang J. Patole, Jameel Ahmed S. Mulla*, Shubham A. Ghare, Rutvik B. Date
Department of Pharmaceutics, Shree Santkrupa College of Pharmacy, Ghogaon - Karad, Maharashtra – 415111 India.
*Corresponding Author
Published In:
Volume - 15,
Issue - 3,
Year - 2024
ABSTRACT:
Diabetes mellitus is a widespread metabolic disorder that results in chronic hyperglycemia due to impairments in insulin secretion, action, or both. This condition contributes significantly to global health burdens and mortality, with India accounting for a substantial share of cases owing to its large diabetic population. Metformin hydrochloride, a first-line treatment for type 2 diabetes, is renowned for its ability to effectively regulate blood sugar levels while maintaining a favorable safety profile. This research focuses on comparing the quality and performance of five Metformin hydrochloride tablet brands available in Satara, Maharashtra. Evaluations were conducted on parameters such as tablet weight uniformity, hardness, friability, disintegration time, drug dissolution behavior, and assay. To further analyze drug release patterns, the dissolution profiles were modeled using kinetic frameworks such as zero-order, first-order, Higuchi, Korsmeyer-Peppas, and Hixson-Crowell equations. The study found that all tablet brands met pharmacopoeial standards for physical attributes, but variations in dissolution profiles were observed. These findings emphasize the importance of quality assessments among different brands to ensure consistent therapeutic outcomes and patient safety. By offering insights into the reliability and performance of Metformin hydrochloride brands, this study aids healthcare providers in selecting effective treatment options for optimal diabetes management.
Cite this article:
Pandurang J. Patole, Jameel Ahmed S. Mulla, Shubham A. Ghare, Rutvik B. Date. Evaluation of Dissolution Behaviour and Physicochemical Characteristics of Five different Brands of Metformin HCl Tablets. Asian Journal of Pharmaceutical Analysis. 2025; 15(3):163-9. doi: 10.52711/2231-5675.2025.00025
Cite(Electronic):
Pandurang J. Patole, Jameel Ahmed S. Mulla, Shubham A. Ghare, Rutvik B. Date. Evaluation of Dissolution Behaviour and Physicochemical Characteristics of Five different Brands of Metformin HCl Tablets. Asian Journal of Pharmaceutical Analysis. 2025; 15(3):163-9. doi: 10.52711/2231-5675.2025.00025 Available on: https://ajpaonline.com/AbstractView.aspx?PID=2024-15-3-1
REFERENCES:
1. Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova K, Duncan BB, Stein C, Basit A, Chan JCN, Mbanya JC, Pavkov ME, Ramachandaran A, Wild SH, James S, Herman WH, Zhang P, Bommer C, Kuo S, Boyko EJ, Magliano DJ. IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2022 Jan; 183:109119. doi: 10.1016/j.diabres.2021.109119. Epub 2021 Dec 6. Erratum in: Diabetes Res Clin Pract. 2023 Oct; 204:110945. doi: 10.1016/j.diabres.2023.110945. PMID: 34879977; PMCID: PMC11057359.
2. World Health Organization. Diabetes. 2020. Available at: https://www.who.int/news-room/fact-sheets/detail/diabetes. Accessed April 8, 2024.
3. International Diabetes Federation. IDF Diabetes Atlas, 10th edition. 2021. Available at: https://www.diabetesatlas.org. Accessed April 3, 2024.
4. Harder T, et al. Global and regional diabetes prevalence among adults aged 20–79 years: Analysis of trends and projections. The Lancet Diabetes & Endocrinology. 2021; 9(12): 803–811. doi: 10.1016/S2213-8587(21)00159-1.
5. Mulla JAS, Aralelimath VR, Tipugade O, Shinde SS, Tetgure NG, Mulla AA, Gavali DD. Formulation and Evaluation of Teneligliptin-Loaded Mucoadhesive Microspheres. 2020; 12(4): 222-227.
6. Mohan V, Anbalagan VP. Expanding role of the Madras Diabetes Research Foundation - Indian Diabetes Risk Score in clinical practice. Indian J Endocrinol Metab. 2013 Jan; 17(1): 31-6. doi: 10.4103/2230-8210.107825. PMID: 23776850; PMCID: PMC3659903.
7. Ashok A. Hajare, Vrushali A. Patil. Formulation and Characterization of Metformin Hydrochloride Floating Tablets. Asian J. Pharm. Res. 2(3): July-Sept. 2012; Page 111-117.
8. Mulla JAS, Hiremath SP, Sharma NK. Repaglinide loaded solid lipid nanoparticles: design and characterization. RGUHS J Pharm Sci. 2010; 2(4): 41-49.
9. J. Bini Janet, K. Kanchana, T. Nirmala. Effect of Structured Teaching Programme on knowledge regarding Foot Care among Patients with Diabetes Mellitus at selected Hospital, Coimbatore. Int. J. of Advances in Nur. Management. 2019; 7(4): 336-338.
10. D. Divya. A Study to Assess the Effectiveness of Structured Teaching Program on Knowledge regarding Gestational Diabetes Mellitus among Antenatal Women at Dr. Bhimrao Ambedkar Memorial Hospital, Raipur, C.G. Int. J. of Advances in Nur. Management. 2021; 9(2): 190-194.
11. Flosy Rodrigues e Menezes. Diabetes Self-Management Education (DSME) effectiveness in people with Type 2 Diabetes Mellitus (T2DM)- A Systematic review. International Journal of Advances in Nursing Management. 2023; 11(3): 210-4.
12. Lizzie Raveendran, Jeyaseelan M. Devadason, Prakash M. Saldanha. Impact of Perceived Self Efficacy on Hba1c among Adolescents with Type 1 Diabetes Mellitus. Int. J. Nur. Edu. and Research 2014; 2(4): 319-323.
13. Hermann LS. Metformin: a review of its pharmacological properties and therapeutic use. Diabete Metab. 1979; 5(3): 233-45. PMID: 387488.
14. Rajan V. Rele. UV Spectrophotometric Estimation of Metformin hydrochloride by Area under Curve Methods in Bulk and Pharmaceutical Dosage Form. Asian J. Research Chem. 2019; 12(3): 187-190.
15. Hazaratali Panari, Vegunarani.M. Study on Complications of Diabetes Mellitus among the Diabetic Patients. Asian J. Nur. Edu. and Research. 2016; 6(2): 171-182.
16. Rena G, Lang CC. Repurposing Metformin for Cardiovascular Disease. Circulation. 2018; 137(5): 422-424. doi: 10.1161/CIRCULATIONAHA.117.031735. PMID: 29378754.
17. Yerevanian A, Soukas AA. Metformin: Mechanisms in Human Obesity and Weight Loss. Curr Obes Rep. 2019 Jun; 8(2): 156-164. doi: 10.1007/s13679-019-00335-3. PMID: 30874963; PMCID: PMC6520185.
18. Rena G, Hardie DG, Pearson ER. The mechanisms of action of metformin. Diabetologia. 2017 Sep; 60(9): 1577-1585. doi: 10.1007/s00125-017-4342-z. Epub 2017 Aug 3. PMID: 28776086; PMCID: PMC5552828.
19. Mulla JS, Dasankoppa FS, Vilas GJ, Sholapur HP. Fast Dissolving Tablets of Promethazine: A Novel Oral Formulation for the Treatment of Fractionated Radiotherapy-Induced Nausea and Emesis. Indian Drugs. 2008; 45(4): 314-317.
20. Mandal S, Ratan GN, Mulla JS, Thimmasetty J, Kaneriya A. Design and In Vitro Evaluation of Gastro Retentive Sustained Release Tablets of Tizanidine Hydrochloride. Indian Journal of Novel Drug Delivery. 2010; 2(4): 144-152.
21. Patil VS, Mulla JAS, Kapse MV. Formulation and evaluation of floating tablets of amla and ginger extract for prolonged gastric retention. Journal of Ethnopharmacology and Toxicology. 2024; 2(2): 1-11.
22. Mulla JA, Suresh S, Khazi IM. Formulation, Characterization and in vitro Evaluation of Methotrexate Solid Lipid Nanoparticles. Research J. Pharm. and Tech. 2009; 2(4): 685-689.
23. Naikawadi AN, Mulla JAS. Review on classification and factors influencing the design of sustained release formulations. World Journal of Drug Delivery. 2023; 1(1): 28-33.
24. Gosavi AA, Thorat PA, Mulla JAS. Formulation and Evaluation of Acyclovir Loaded Transferosomal Gel for Transdermal Drug Delivery. J. Drug Delivery Ther. 2024; 14(9):122-30.
25. Dipen Patel, DM Patel, ST Prajapati, JB Dave, CN Patel. Design and Evaluation of Modified Release Dosage Form Containing Bupropion Hydrochloride. Research J. Pharma. Dosage Forms and Tech. 2010; 2(1):47-51.
26. Debjit Bhowmik, Amrendra Singh, Praveen Khirwadkar, Nishi Shukla, Vikas Kumar Chaudhari. Formulation and Evaluation of Methyl Phenidate Sustained Release Tablets. Res. J. Pharm. Dosage Form. and Tech. 2016; 8(3): 199-206.
27. Mabrouk M, Mulla JAS, Kumar P, Chejara DR, Badhe RV, Choonara YE, Toit LC, Pillay V. Intestinal targeting of ganciclovir release employing a novel HEC-PAA blended lyomatrix. AAPS PharmScitech. 2016; 17:1120-1130.
28. Jamakandi VG, Mulla JS, Vinay BL, Shivakumar HN. Formulation, characterization, and evaluation of matrix-type transdermal patches of a model antihypertensive drug. Asian Journal of Pharmaceutics. 2009; 3(1): 59-65.
29. Mukund G Tawar, PD Chaudhari. Design and Dissolution Study of Colon Specific Drug Delivery System of Tinidazole. Research J. Pharm. and Tech. 2009; 2(4): 862-864.